Manufacturers Life Insurance Company, The Aligos Therapeutics, Inc. Transaction History

Manufacturers Life Insurance Company, The

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 20, 2022	SELL	$2.08 - $12.2 $26,613 - $156,099	-12,795 Closed	0 $0
Q4 2021 Feb 16, 2022	BUY	$11.48 - $17.69 $5,958 - $9,181	519 Added 4.23%	12,795 $152,000
Q3 2021 Nov 12, 2021	BUY	$14.57 - $17.72 $17,367 - $21,122	1,192 Added 10.75%	12,276 $190,000
Q2 2021 Aug 12, 2021	BUY	$20.3 - $33.6 $225,005 - $372,422	11,084 New	11,084 $226,000

227K

Ticker ALGS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,717,000
Market Cap $1.3B
Description
Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases. Its lead drug candidate is ALG-010133, a s-antigen transport-inhibiting oligonucleotide polymer that is in Phase Ib clinical trial for the treatment of chronic hepatitis B (CHB);...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.